Holen Sie sich die Stockscreener-App
12.11
4.85%
-0.625
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$12.73
Offen:
$12.55
24-Stunden-Volumen:
1.16M
Relative Volume:
0.26
Marktkapitalisierung:
$2.43B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
-5.8478
EPS:
-2.07
Netto-Cashflow:
$365.00M
1W Leistung:
-9.13%
1M Leistung:
-5.44%
6M Leistung:
-10.47%
1J Leistung:
-20.99%
1-Tages-Spanne:
$12.08
$12.69
1-Wochen-Bereich:
$12.08
$13.19
52-Wochen-Spanne:
$9.85
$17.18
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
12.16 | 2.54B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
476.76 | 175.03B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
159.25 | 46.42B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
78.78 | 39.37B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
233.50 | 34.98B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
41.47 | 34.41B | 28.43B | 1.16B | 1.26B | 1.4457 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-19 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-11-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
Dental Laboratories Market Set to Witness Significant Growth - openPR.com
Gamco Investors Boosts Stake in DENTSPLY SIRONA - National Today
American Century Companies Inc. Boosts Stake in DENTSPLY SIRONA Inc. - National Today
American Century Companies Inc. Has $19.08 Million Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply Sirona gains as BofA upgrades to buy on risk-reward setup - MSN
A Look At Dentsply Sirona (XRAY) Valuation After Earnings Miss And Softer 2026 Outlook - Sahm
DENTSPLY SIRONA (XRAY) Insider Gregory T. Lucier Buys 15,000 Shares at $12.45, Boosting Stake 30% - AlphaStreet
XRAY: Turnaround strategy centers on execution, innovation, and targeted investments for long-term growth - TradingView
Insider Buying: James Forbes Acquires Additional Shares of Dents - GuruFocus
James Forbes Acquires 5,000 Shares of DENTSPLY SIRONA (NASDAQ:XRAY) Stock - MarketBeat
DENTSPLY SIRONA (NASDAQ:XRAY) Director Gregory Lucier Acquires 15,000 Shares - MarketBeat
Dentsply Sirona (XRAY) Showcases Advancements in Dental-dedicated MRI Technology - GuruFocus
3 Stocks Under $50 Walking a Fine Line - Finviz
Dentsply Sirona and Siemens Healthineers Announce FDA Clearance of First Dental-Dedicated MRI System, MAGNETOM Free.Max Dental Edition - Quiver Quantitative
New dental MRI scans jaws without ionizing radiation after FDA nod - Stock Titan
Dental Suction System Market In-Depth Insights, Business - openPR.com
A Look At Dentsply Sirona (XRAY) Valuation After Mixed Earnings And Impairment Charges - Yahoo Finance
Dentsply Sirona Broadens US Reach As Board Refresh Shapes Growth Story - Sahm
Dentsply Sirona Stock Soars 15.5%, Hits Intraday High of $14.76 - Markets Mojo
How rising interest rates impact DENTSPLY SIRONA Inc. stock2026 EndofMonth & Low Drawdown Investment Ideas - Naître et grandir
180,542 Shares in DENTSPLY SIRONA Inc. $XRAY Acquired by Neo Ivy Capital Management - MarketBeat
Quantbot Technologies LP Sells 114,223 Shares of DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Envista, Baxter, Artivion, Dentsply Sirona, and Cigna Stocks Trade Down, What You Need To Know - The Globe and Mail
DENTSPLY SIRONA (NASDAQ:XRAY) Trading Down 7.5%Time to Sell? - MarketBeat
Dentsply Sirona (XRAY) Added by Ariel Fund as Strategic Reset Targets Long-Term Growth - Yahoo Finance
110,000 Shares in DENTSPLY SIRONA Inc. $XRAY Purchased by Truepoint Inc. - MarketBeat
DENTSPLY SIRONA (XRAY) Is Up 5.0% After Impairment Charges And New Guidance Reset Expectations – What’s Changed - Sahm
Wisdom Bioscience forms science advisory board - DrBicuspid.com
Mechanical Dental Articulators Market Set for Dynamic - openPR.com
Hedge Fund and Insider Trading News: Leopold Aschenbrenner, Daniel Loeb, Bill Ackman, Scott Bessent, Taproot Management, Saba Capital, TCI Fund Management, Brevan Howard, DENTSPLY SIRONA Inc (XRAY), Coca-Cola Co (KO), and More - Insider Monkey
DENTSPLY SIRONA Inc. $XRAY Shares Bought by Kingsview Wealth Management LLC - National Today
“Complication management is not failure; it is part of responsible implant care” - Dental Tribune US
DENTSPLY SIRONA (XRAY) Q4 2025 Earnings Transcript - AOL.com
DENTSPLY SIRONA Inc. $XRAY Shares Acquired by Skba Capital Management LLC - MarketBeat
Zacks Research Upgrades DENTSPLY SIRONA (NASDAQ:XRAY) to Hold - MarketBeat
Dentsply Sirona (XRAY -7.1%): Geopolitical Shock Rattles Markets - Trefis
Insider Buying: DENTSPLY SIRONA (NASDAQ:XRAY) Director Acquires 22,445 Shares of Stock - MarketBeat
Insider Buying: DENTSPLY SIRONA (NASDAQ:XRAY) Director Acquires $392,383.20 in Stock - MarketBeat
Trust linked to DENTSPLY SIRONA (XRAY) director reports 50,000-share buy - Stock Titan
Insider Buying: James Forbes Acquires Shares of Dentsply Sirona Inc (XRAY) - GuruFocus
DENTSPLY SIRONA (XRAY) SVP receives 9,599-share stock award in Form 4 - Stock Titan
Dentsply Sirona (XRAY) SVP awarded 8,861 common shares in Form 4 - Stock Titan
Director James D. Forbes buys 5,000 DENTSPLY SIRONA (XRAY) shares in market trade - Stock Titan
Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2026 - Bitget
DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating a Challenging Landscape with Insights into Valuation and Dividend Potential - DirectorsTalk Interviews
Don't Overlook Dentsply (XRAY) International Revenue Trends While Assessing the Stock - Nasdaq
XRAY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Dentsply Compules Tips Aazon.co: Dentsply Sirona 642220 TPH Spectra ST Low Viscosity Spectrum Dental - hotelier.com.py
Dentsply Sirona, Burkhart expand distribution partnership - DrBicuspid.com
Intech Investment Management Buys $3.4M Stake in DENTSPLY SIRONA - National Today
Mizuho raises Dentsply Sirona stock price target on restructuring By Investing.com - Investing.com UK
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Dentsply Sirona Inc-Aktie (XRAY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Forbes James D | Director |
Mar 09 '26 |
Buy |
12.48 |
5,000 |
62,400 |
10,000 |
| LUCIER GREGORY T | Director |
Mar 02 '26 |
Buy |
14.24 |
27,555 |
392,521 |
27,555 |
| LUCIER GREGORY T | Director |
Mar 03 '26 |
Buy |
14.03 |
22,445 |
314,858 |
50,000 |
2.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):